Literature DB >> 32631996

A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver.

Heng Wu1,2, Tzachi Reizel3, Yue J Wang3, Jessica L Lapiro1,2, Betsy T Kren4, Jonathan Schug3, Shilpa Rao3, Ashleigh Morgan3, Adam Herman5, Laurie L Shekels1,4, Matthew S Rassette4, Andrew N Lane6, Teresa Cassel6, Teresa W M Fan6, Juan C Manivel7, Sumedha Gunewardena8, Udayan Apte9, Piotr Sicinski10,11, Klaus H Kaestner3, Jeffrey H Albrecht12,2.   

Abstract

Hepatocyte nuclear factor 4α (HNF4α) is a master regulator of liver function and a tumor suppressor in hepatocellular carcinoma (HCC). In this study, we explore the reciprocal negative regulation of HNF4α and cyclin D1, a key cell cycle protein in the liver. Transcriptomic analysis of cultured hepatocyte and HCC cells found that cyclin D1 knockdown induced the expression of a large network of HNF4α-regulated genes. Chromatin immunoprecipitation-sequencing (ChIP-seq) demonstrated that cyclin D1 inhibits the binding of HNF4α to thousands of targets in the liver, thereby diminishing the expression of associated genes that regulate diverse metabolic activities. Conversely, acute HNF4α deletion in the liver induces cyclin D1 and hepatocyte cell cycle progression; concurrent cyclin D1 ablation blocked this proliferation, suggesting that HNF4α maintains proliferative quiescence in the liver, at least, in part, via repression of cyclin D1. Acute cyclin D1 deletion in the regenerating liver markedly inhibited hepatocyte proliferation after partial hepatectomy, confirming its pivotal role in cell cycle progression in this in vivo model, and enhanced the expression of HNF4α target proteins. Hepatocyte cyclin D1 gene ablation caused markedly increased postprandial liver glycogen levels (in a HNF4α-dependent fashion), indicating that the cyclin D1-HNF4α axis regulates glucose metabolism in response to feeding. In AML12 hepatocytes, cyclin D1 depletion led to increased glucose uptake, which was negated if HNF4α was depleted simultaneously, and markedly elevated glycogen synthesis. To summarize, mutual repression by cyclin D1 and HNF4α coordinately controls the cell cycle machinery and metabolism in the liver.

Entities:  

Keywords:  cell cycle; glycogen; liver regeneration; partial hepatectomy; pyruvate carboxylase

Mesh:

Substances:

Year:  2020        PMID: 32631996      PMCID: PMC7382236          DOI: 10.1073/pnas.2002898117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  58 in total

Review 1.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 2.  Elucidating the metabolic regulation of liver regeneration.

Authors:  Jiansheng Huang; David A Rudnick
Journal:  Am J Pathol       Date:  2013-10-17       Impact factor: 4.307

Review 3.  Hepatic expression and cellular distribution of the glucose transporter family.

Authors:  Sumera Karim; David H Adams; Patricia F Lalor
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 4.  Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2017-08-31       Impact factor: 27.287

5.  Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.

Authors:  Chad Walesky; Genea Edwards; Prachi Borude; Sumedha Gunewardena; Maura O'Neil; Byunggil Yoo; Udayan Apte
Journal:  Hepatology       Date:  2013-06       Impact factor: 17.425

Review 6.  Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Authors:  Per Hydbring; Marcos Malumbres; Piotr Sicinski
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

7.  Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.

Authors:  Eric A Hanse; Douglas G Mashek; Jennifer R Becker; Ashley D Solmonson; Lisa K Mullany; Mara T Mashek; Howard C Towle; Anhtung T Chau; Jeffrey H Albrecht
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

Review 8.  Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids.

Authors:  Hong Lu
Journal:  Acta Pharm Sin B       Date:  2016-07-28       Impact factor: 11.413

9.  Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks.

Authors:  Meng Qu; Tomas Duffy; Tsuyoshi Hirota; Steve A Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

10.  A human liver cell atlas reveals heterogeneity and epithelial progenitors.

Authors:  Antonio Saviano; Nadim Aizarani; Laurent Mailly; Sarah Durand; Josip S Herman; Patrick Pessaux; Thomas F Baumert; Dominic Grün
Journal:  Nature       Date:  2019-07-10       Impact factor: 49.962

View more
  12 in total

1.  HDAC6/FOXP3/HNF4α axis promotes bile acids induced gastric intestinal metaplasia.

Authors:  Luyao Zhang; Na Wang; Min Chen; Siran Wu; Jiaoxia Zeng; Fenli Zhou; Qiong Wu; Junye Liu; Yongquan Shi
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Genetic and Molecular Characterization of the Immortalized Murine Hepatic Stellate Cell Line GRX.

Authors:  Sarah K Schröder; Herdit M Schüler; Kamilla V Petersen; Cinzia Tesauro; Birgitta R Knudsen; Finn S Pedersen; Frederike Krus; Eva M Buhl; Elke Roeb; Martin Roderfeld; Radovan Borojevic; Jamie L Almeida; Ralf Weiskirchen
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

3.  PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α-GLUT2 pathway.

Authors:  Peihua Liu; Ling Jiang; Weimin Kong; Qiushi Xie; Ping Li; Xiaonan Liu; Jiayi Zhang; Ming Liu; Zhongjian Wang; Liang Zhu; Hanyu Yang; Ying Zhou; Jianjun Zou; Xiaodong Liu; Li Liu
Journal:  Acta Pharm Sin B       Date:  2021-10-16       Impact factor: 14.903

Review 4.  Therapeutic Potential of HNF4α in End-stage Liver Disease.

Authors:  Ricardo Diaz-Aragon; Michael C Coard; Sriram Amirneni; Lanuza Faccioli; Nils Haep; Michelle R Malizio; Takashi Motomura; Zehra N Kocas-Kilicarslan; Alina Ostrowska; Rodrigo M Florentino; Carla Frau
Journal:  Organogenesis       Date:  2021-10-02       Impact factor: 2.316

5.  An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma.

Authors:  Long Liu; Zaoqu Liu; Lingfang Meng; Lifeng Li; Jie Gao; Shizhe Yu; Bowen Hu; Han Yang; Wenzhi Guo; Shuijun Zhang
Journal:  Front Mol Biosci       Date:  2021-12-14

6.  Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma.

Authors:  Lingyu Zhang; Yu Li; Yibei Dai; Danhua Wang; Xuchu Wang; Ying Cao; Weiwei Liu; Zhihua Tao
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

7.  HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/β-Catenin Pathway.

Authors:  Hong-Mei Ma; Qian Zhang; Xue-Mei Yang; Yan Hu; Juan Zhang; Lin Chen; Bin Zhao; Wen-Ting Yang; Rui Xu
Journal:  Oxid Med Cell Longev       Date:  2022-01-28       Impact factor: 6.543

Review 8.  Degradation strategy of cyclin D1 in cancer cells and the potential clinical application.

Authors:  Shuyi Chen; Ling Li
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

9.  [Curcumol inhibits keloid fibroblast proliferation and collagen synthesis through the ERK signaling pathway].

Authors:  W Yuan; H Sun; L Yu; J Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20

Review 10.  Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.

Authors:  Vanessa Dubois; Bart Staels; Philippe Lefebvre; Michael P Verzi; Jérôme Eeckhoute
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.